JOINT INJURY

Joint injuries include a variety of problems affecting the joints, such as cartilage, ligaments, and tendons. These injuries can occur from trauma, degenerative wear and tear, or autoimmune diseases such as arthritis. The most commonly affected joints include the knees, hips, shoulders, and elbows. Joint injuries can significantly limit mobility and lead to chronic pain. If left untreated, they can lead to irreversible damage, such as osteoarthritis. Traditional treatments include physical therapy, anti-inflammatory medications, and in more severe cases, surgery.

The most common symptoms of a joint injury include pain in the affected joint, swelling, stiffness, and loss of movement. Depending on the severity, the pain can range from mild discomfort to a severe inability to move the joint. In addition, joint injuries can cause a feeling of weakness or instability in the joint. In advanced cases, such as osteoarthritis, there may be cracking or popping sounds during movement and deformities in the joint structure.

Mesenchymal stem cells have emerged as an advanced treatment option for joint injuries as they have the ability to differentiate into chondrocytes, the cells that form cartilage. When injected into damaged joints, MSCs can help regenerate damaged cartilage and reduce chronic inflammation, thereby improving joint function. In addition, these cells can release growth factors that promote the repair of surrounding tissue, such as ligaments and tendons.

Mesenchymal stem cell treatment for joint injuries can reduce pain, improve mobility, and slow the progression of degenerative conditions such as osteoarthritis. Studies have shown that MSCs can significantly help, regenerating cartilage and partially restoring joint functionality. Additionally, by reducing inflammation, these therapies offer a long-term solution for those suffering from chronic pain and limited movement.